This session will cover the collection and use of Real-World Evidence over the entire development and delivery cycle of new therapeutics. Speakers will define the space and then explore the challenges and opportunities of applying Real World Evidence to various aspects of product development. This panel will discuss regulatory considerations in retrospective and prospective research designs, advanced data capture methods, and support for medical decision-making. Special focus will be given to integrating wide-ranging observational data and outcomes of non-traditional clinical trial into the drug development process.

Session ID: 24426